G. Jemec and A. B. Kimball, Hidradenitis suppurativa: Epidemiology and scope of the problem, Journal of the American Academy of Dermatology, vol.73, issue.5, pp.4-7, 2015.

G. Jemec, M. Heidenheim, and N. H. Nielsen, The prevalence of hidradenitis suppurativa and its potential precursor lesions, Journal of the American Academy of Dermatology. août, vol.35, issue.2, pp.191-195, 1996.

J. E. Revuz, F. Canoui-poitrine, P. Wolkenstein, C. Viallette, G. Gabison et al., Prevalence and factors associated with hidradenitis suppurativa: Results from two case-control studies, Journal of the American Academy of Dermatology, vol.59, issue.4, pp.596-601, 2008.

M. Richard, F. Corgibet, M. Beylot-barry, A. Barbaud, C. Bodemer et al., Sex-and age-adjusted prevalence estimates of five chronic inflammatory skin diseases in France: results of the « OBJECTIFS PEAU » study, Journal of the European Academy of Dermatology and Venereology, vol.32, issue.11, pp.1967-71, 2018.

J. R. Ingram, S. Jenkins-jones, D. W. Knipe, C. Morgan, R. Cannings-john et al., Population-based Clinical Practice Research Datalink study using algorithm modelling to identify the true burden of hidradenitis suppurativa, British Journal of Dermatology. avr, vol.178, issue.4, pp.917-941, 2018.

I. Cosmatos, A. Matcho, R. Weinstein, M. O. Montgomery, and P. Stang, Analysis of patient claims data to determine the prevalence of hidradenitis suppurativa in the United States, Journal of the American Academy of Dermatology. mars, vol.68, issue.3, pp.412-421, 2013.

B. G. Vazquez, A. Alikhan, A. L. Weaver, D. A. Wetter, and M. D. Davis, Incidence of Hidradenitis Suppurativa and Associated Factors: A Population-Based Study of Olmsted County, Minnesota, Journal of Investigative Dermatology. janv, vol.133, issue.1, pp.97-103, 2013.

A. Garg, J. S. Kirby, J. Lavian, G. Lin, and A. Strunk, Sex-and Age-Adjusted Population Analysis of Prevalence Estimates for Hidradenitis Suppurativa in the United States, JAMA Dermatology. 1 août, vol.153, issue.8, p.760, 2017.

J. Revuz, Hidradenitis suppurativa, Journal of the European Academy of Dermatology and Venereology. sept, vol.23, issue.9, pp.985-98, 2009.

I. E. Deckers, H. H. Van-der-zee, J. Boer, and E. P. Prens, Correlation of early-onset hidradenitis suppurativa with stronger genetic susceptibility and more widespread involvement, Journal of the American Academy of Dermatology. mars, vol.72, issue.3, pp.485-493, 2015.

C. Dessinioti, V. Tzanetakou, C. Zisimou, G. Kontochristopoulos, and C. Antoniou, A retrospective study of the characteristics of patients with early-onset compared to adult-onset hidradenitis suppurativa, International Journal of Dermatology. juin, vol.57, issue.6, pp.687-91, 2018.

Y. M. Mengesha, T. C. Holcombe, and R. C. Hansen, Prepubertal hidradenitis suppurativa: two case reports and review of the literature, Pediatr Dermatol. août, vol.16, issue.4, pp.292-298, 1999.

R. A. Palmer and M. Keefe, Early-onset hidradenitis suppurativa, Clin Exp Dermatol. sept, vol.26, issue.6, pp.501-504, 2001.

M. Feito-rodríguez, E. Sendagorta-cudós, P. Herranz-pinto, and R. De-lucas-laguna, Prepubertal Hidradenitis Suppurativa Successfully Treated with Botulinum Toxin A: Dermatologic Surgery, août, vol.35, issue.8, pp.1300-1302, 2009.

J. Stojkovic-filipovic, M. Gajic-veljic, and M. Nikolic, Prepubertal onset of hidradenitis suppurativa in a girl: A case report and literature review, Indian Journal of Dermatology, vol.81, issue.3, p.294, 2015.

J. Loget, C. Saint-martin, P. Guillem, L. Kanagaratnam, P. Becherel et al., Errance médicale des patients atteints d'hidradénite suppurée : un problème majeur et persistant, vol.145, pp.331-339, 2018.

D. M. Saunte, J. Boer, A. Stratigos, J. C. Szepietowski, I. Hamzavi et al., Diagnostic delay in hidradenitis suppurativa is a global problem, British Journal of Dermatology. déc, vol.173, issue.6, pp.1546-1555, 2015.

F. Canoui-poitrine, J. E. Revuz, P. Wolkenstein, C. Viallette, G. Gabison et al., Clinical characteristics of a series of 302 French patients with hidradenitis suppurativa, with an analysis of factors associated with disease severity, Journal of the American Academy of Dermatology. juill, vol.61, issue.1, pp.51-58, 2009.

K. Sartorius, L. Emtestam, G. Jemec, and J. Lapins, Objective scoring of hidradenitis suppurativa reflecting the role of tobacco smoking and obesity, British Journal of Dermatology, vol.161, issue.4, pp.831-840, 2009.

A. Grant, T. Gonzalez, M. O. Montgomery, V. Cardenas, and F. A. Kerdel, Infliximab therapy for patients with moderate to severe hidradenitis suppurativa: A randomized, double-blind, placebo-controlled crossover trial, Journal of the American Academy of Dermatology. févr, vol.62, issue.2, pp.205-222, 2010.

L. K. Hoffman, M. H. Ghias, and M. A. Lowes, Pathophysiology of hidradenitis suppurativa, Semin Cutan Med Surg. juin, vol.36, issue.2, pp.47-54, 2017.

C. B. Kromann, I. E. Deckers, S. Esmann, J. Boer, E. P. Prens et al., Risk factors, clinical course and long-term prognosis in hidradenitis suppurativa: a cross-sectional study, British Journal of Dermatology, vol.171, issue.4, pp.819-843, 2014.

R. F. Edlich, K. A. Silloway, G. T. Rodeheaver, and P. H. Cooper, Epidemiology, pathology, and treatment of axillary hidradenitis suppurativa, J Emerg Med, vol.4, issue.5, pp.369-78, 1986.

B. J. Harrison, G. F. Read, and L. E. Hughes, Endocrine basis for the clinical presentation of hidradenitis suppurativa, Br J Surg. oct, vol.75, issue.10, pp.972-977, 1988.

R. Rompel and J. Petres, Long-term results of wide surgical excision in 106 patients with hidradenitis suppurativa, Dermatol Surg. juill, vol.26, issue.7, pp.638-681, 2000.

T. Tzellos, C. C. Zouboulis, W. Gulliver, A. D. Cohen, P. Wolkenstein et al., Cardiovascular disease risk factors in patients with hidradenitis suppurativa: a systematic review and meta-analysis of observational studies, British Journal of Dermatology, vol.173, issue.5, pp.1142-55, 2015.

C. Kromann, K. Ibler, V. Kristiansen, and G. Jemec, The Influence of Body Weight on the Prevalence and Severity of Hidradenitis Suppurativa, Acta Dermato Venereologica, vol.94, issue.5, pp.553-560, 2014.

P. R. Mikkelsen, D. N. Dufour, K. Zarchi, and G. Jemec, Recurrence Rate and Patient Satisfaction of CO2 Laser Evaporation of Lesions in Patients With Hidradenitis Suppurativa: A Retrospective Study, Dermatologic Surgery. févr, vol.41, issue.2, pp.255-60, 2015.

G. A. Knaysi, B. Cosman, and G. F. Crikelair, Hidradenitis suppurativa, JAMA. 1 janv, vol.203, issue.1, pp.19-22, 1968.

B. J. Harrison, S. Kumar, G. F. Read, C. A. Edwards, M. F. Scanlon et al., Hidradenitis suppurativa: evidence for an endocrine abnormality, Br J Surg. déc, vol.72, issue.12, pp.1002-1006, 1985.

A. Garg, V. Papagermanos, M. Midura, and A. Strunk, Incidence of hidradenitis suppurativa among tobacco smokers: a population-based retrospective analysis in the U, S.A. British Journal of Dermatology. mars, vol.178, issue.3, pp.709-723, 2018.

G. Denny and M. J. Anadkat, The effect of smoking and age on the response to first-line therapy of hidradenitis suppurativa: An institutional retrospective cohort study, Journal of the American Academy of Dermatology. janv, vol.76, issue.1, pp.54-63, 2017.

J. S. Fitzsimmons and P. R. Guilbert, A family study of hidradenitis suppurativa, Journal of Medical Genetics, vol.22, issue.5, pp.367-73, 1985.

A. E. Pink, M. A. Simpson, N. Desai, D. Dafou, A. Hills et al., Mutations in the ?-secretase genes NCSTN, PSENEN, and PSEN1 underlie rare forms of hidradenitis suppurativa (acne inversa), J Invest Dermatol, vol.132, issue.10, pp.2459-61, 2012.

A. Schrader, I. E. Deckers, H. H. Van-der-zee, J. Boer, and E. P. Prens, Hidradenitis suppurativa: a retrospective study of 846 Dutch patients to identify factors associated with disease severity, J Am Acad Dermatol. sept, vol.71, issue.3, pp.460-467, 2014.

J. W. Frew, D. A. Vekic, J. A. Woods, and G. D. Cains, Drug-associated hidradenitis suppurativa: A systematic review of case reports, Journal of the American Academy of Dermatology. janv, vol.78, issue.1, pp.217-219, 2018.

J. E. Revuz and G. Jemec, Diagnosing Hidradenitis Suppurativa, Dermatologic Clinics. janv, vol.34, issue.1, pp.1-5, 2016.

C. C. Zouboulis, N. Desai, L. Emtestam, R. E. Hunger, D. Ioannides et al., European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa, Journal of the European Academy of Dermatology and Venereology. avr, vol.29, issue.4, pp.619-663, 2015.

C. C. Zouboulis, V. Del-marmol, U. Mrowietz, E. P. Prens, T. Tzellos et al., Hidradenitis Suppurativa/Acne Inversa: Criteria for Diagnosis, Severity Assessment, Classification and Disease Evaluation, Dermatology, vol.231, issue.2, pp.184-90, 2015.

H. Hurley, Axillary hyperhidrosis, apocrine bromhidrosis, hidradenitis suppurativa, and familial benign pemphigus: surgical approach, pp.729-739, 1989.

B. Horváth, I. Janse, J. Blok, R. Driessen, J. Boer et al., Hurley Staging Refined: A Proposal by the Dutch Hidradenitis Suppurativa Expert Group, Acta Dermato Venereologica, vol.97, issue.3, pp.412-415, 2017.

J. Revuz, Modifications et mode d'emploi du score de Sartorius pour évaluer la gravité de l'hidradénite suppurée. Annales de Dermatologie et de Vénéréologie, févr, vol.134, issue.2, pp.173-177, 2007.

A. B. Kimball, F. Kerdel, D. Adams, U. Mrowietz, J. M. Gelfand et al., Adalimumab for the Treatment of Moderate to Severe Hidradenitis Suppurativa, p.19

A. B. Kimball, J. M. Sobell, C. C. Zouboulis, Y. Gu, D. A. Williams et al., Hidradenitis Suppurativa Clinical Response): a novel clinical endpoint to evaluate therapeutic outcomes in patients with hidradenitis suppurativa from the placebo-controlled portion of a phase 2 adalimumab study, Journal of the European Academy of Dermatology and Venereology. juin, vol.30, issue.6, pp.989-94, 2016.

C. C. Zouboulis, T. Tzellos, A. Kyrgidis, G. Jemec, F. G. Bechara et al., Development and validation of the International Hidradenitis Suppurativa Severity Score System (IHS4), a novel dynamic scoring system to assess HS severity, British Journal of Dermatology, vol.177, issue.5, pp.1401-1410, 2017.

H. Yildiz, L. Senol, E. Ercan, and M. E. Bilgili, Karabudak Abuaf O. A prospective randomized controlled trial assessing the efficacy of adjunctive hyperbaric oxygen therapy in the treatment of hidradenitis suppurativa, International Journal of Dermatology. févr, vol.55, issue.2, pp.232-239, 2016.

?. Matusiak, A. Bieniek, and J. C. Szepietowski, Acitretin treatment for hidradenitis suppurativa: a prospective series of 17 patients, British Journal of Dermatology. juill, vol.171, issue.1, pp.170-174, 2014.

M. Amano, A. Grant, and F. A. Kerdel, A prospective open-label clinical trial of adalimumab for the treatment of hidradenitis suppurativa: Adalimumab for treating hidradenitis suppurativa, International Journal of Dermatology. 19 juill, vol.49, issue.8, pp.950-955, 2010.

S. Hessam, L. Scholl, M. Sand, L. Schmitz, S. Reitenbach et al., A Novel Severity Assessment Scoring System for Hidradenitis Suppurativa, JAMA Dermatology. 1 mars, vol.154, issue.3, p.330, 2018.

K. Peris, L. Schiavo, A. Fabbrocini, G. Dini, V. Patrizi et al., HIDRAdisk: validation of an innovative visual tool to assess the burden of hidradenitis suppurativa, Journal of the European Academy of Dermatology and Venereology. avr, vol.33, issue.4, pp.766-73, 2019.

M. Gooderham and K. Papp, The psychosocial impact of hidradenitis suppurativa, Journal of the American Academy of Dermatology, vol.73, issue.5, pp.19-22, 2015.

N. Kluger, H. Sintonen, M. Ranta, and M. Serlachius, Health-Related Quality of Life of Patients with Hidradenitis Suppurativa Measured with the 15D Instrument and Comparison with the General Population and Patients with Psoriasis, Skin Appendage Disorders, vol.4, issue.3, pp.131-136, 2018.

C. Mclellan, M. Sisic, H. H. Oon, and J. Tan, Preliminary Validation of the HS-QoL: A Quality-of-Life Measure for Hidradenitis Suppurativa, Journal of Cutaneous Medicine and Surgery. mars, vol.22, issue.2, pp.142-148, 2018.

M. Sisic, J. S. Kirby, S. Boyal, L. Plant, C. Mclellan et al., Development of a Quality-of-Life Measure for Hidradenitis Suppurativa, Journal of Cutaneous Medicine and Surgery. mars, vol.21, issue.2, pp.152-157, 2017.

K. R. Van-straalen, T. Verhagen, B. Horváth, C. Ardon, A. Vossen et al., 56. van der Zee HH, Jemec GBE. New insights into the diagnosis of hidradenitis suppurativa: Clinical presentations and phenotypes, Journal of the American Academy of Dermatology. sept, vol.79, issue.3, pp.23-29, 2015.

B. Moriarty, A. Pink, D. Creamer, and N. Desai, Hidradenitis suppurativa fulminans: a clinically distinct phenotype?, British Journal of Dermatology. déc, vol.171, issue.6, pp.1576-1584, 2014.

D. C. Van-rappard, M. V. Starink, A. C. Van-der-wal, M. A. De-rie, and J. R. Mekkes, Four cases of plaque form hidradenitis suppurativa, Journal of the European Academy of Dermatology and Venereology, vol.30, issue.10, pp.104-110, 2016.

I. Jansen, P. Altmeyer, and G. Piewig, Acne inversa (alias hidradenitis suppurativa), J Eur Acad Dermatol Venereol, vol.15, issue.6, pp.532-572, 2001.

J. Gasparic, T. Riis, P. Jemec, and G. B. , Recognizing syndromic hidradenitis suppurativa: a review of the literature, Journal of the European Academy of Dermatology and Venereology, vol.31, issue.11, pp.1809-1825, 2017.

J. L. Hsiao, R. J. Antaya, T. Berger, T. Maurer, K. Shinkai et al., Hidradenitis Suppurativa and Concomitant Pyoderma Gangrenosum: A Case Series and Literature Review. Archives of Dermatology, vol.146, 2010.

M. Braun-falco, O. Kovnerystyy, P. Lohse, and T. Ruzicka, Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH)?a new autoinflammatory syndrome distinct from PAPA syndrome, Journal of the American Academy of Dermatology. mars, vol.66, issue.3, pp.409-424, 2012.

N. Garzorz, V. Papanagiotou, A. Atenhan, C. Andres, S. Eyerich et al., Pyoderma gangrenosum, acne, psoriasis, arthritis and suppurative hidradenitis (PAPASH)-syndrome: a new entity within the spectrum of autoinflammatory syndromes, Journal of the European Academy of Dermatology and Venereology. janv, vol.30, issue.1, pp.141-144, 2016.

M. Leuenberger, J. Berner, D. Lucca, J. Fischer, L. Kaparos et al., PASS Syndrome: An IL-1-Driven Autoinflammatory Disease, Dermatology, vol.232, issue.2, pp.254-262, 2016.

C. Vinkel and S. F. Thomsen, Autoinflammatory syndromes associated with hidradenitis suppurativa and/or acne, International Journal of Dermatology. août, vol.56, issue.8, pp.811-819, 2017.

A. V. Marzano, G. Damiani, I. Ceccherini, B. E. Gattorno, M. Cugno et al., Autoinflammation in pyoderma gangrenosum and its syndromic form (pyoderma gangrenosum, acne and suppurative hidradenitis), British Journal of Dermatology. juin, vol.176, issue.6, pp.1588-98, 2017.

G. Plewig, A. A. Kligman, and . Conglobata, Acne, vol.1975, pp.168-203

C. C. Zimmermann, D. Sforza, P. M. Macedo, . De, L. Azulay-abulafia et al., Dowling-Degos disease: classic clinical and histopathological presentation. An Bras Dermatol, vol.86, pp.979-82, 2011.

D. J. Ralser, F. Basmanav, A. Tafazzoli, J. Wititsuwannakul, S. Delker et al., Mutations in ?-secretase subunitencoding PSENEN underlie Dowling-Degos disease associated with acne inversa, J Clin Invest. 3 avr, vol.127, issue.4, pp.1485-90, 2017.

D. J. Ralser, H. Takeuchi, G. Fritz, F. B. Basmanav, M. Effern et al., Altered Notch Signaling in Dowling-Degos Disease: Additional Mutations in POGLUT1 and Further Insights into Disease Pathogenesis, J Invest Dermatol. avr, vol.139, issue.4, pp.960-964, 2019.

Y. C. Kim, M. Davis, C. F. Schanbacher, and W. Su, Dowling-Degos disease (reticulate pigmented anomaly of the flexures): A clinical and histopathologic study of 6 cases, Journal of the American Academy of Dermatology. mars, vol.40, issue.3, pp.462-469, 1999.

J. Blok, M. Jonkman, and B. Horváth, The possible association of hidradenitis suppurativa and Down syndrome: is increased amyloid precursor protein expression resulting in impaired Notch signalling the missing link?, Br J Dermatol. juin, vol.170, issue.6, pp.1375-1382, 2014.

J. R. Montgomery, T. W. White, B. L. Martin, M. L. Turner, and S. M. Holland, A novel connexin 26 gene mutation associated with features of the keratitis-ichthyosis-deafness syndrome and the follicular occlusion triad, J Am Acad Dermatol. sept, vol.51, issue.3, pp.377-82, 2004.

A. Yung and J. A. Newton-bishop, A case of Bazex-Dupré-Christol syndrome associated with multiple genital trichoepitheliomas: Correspondence, British Journal of Dermatology. 5 août, vol.153, issue.3, pp.682-686, 2005.

M. V. Gonfiantini, A. M. Pucciarini, M. L. Macchiaiolo, M. Buonuomo, P. S. Diociaiuti et al., Borderline cognitive level in a family with Bazex-Dupré-Christol syndrome, American Journal of Medical Genetics Part A. juill, vol.167, issue.7, pp.1637-1680, 2015.

P. Todd, J. Garioch, M. Rademaker, W. Susskind, C. Gemell et al., Pachyonychia congenita complicated by hidradenitis suppurativa: a family study, Br J Dermatol, vol.123, issue.5, pp.663-669, 1990.

L. S. Ostlere, J. A. Langtry, P. S. Mortimer, and R. C. Staughton, Hidradenitis suppurativa in Crohn's disease, Br J Dermatol. oct, vol.125, issue.4, pp.384-390, 1991.

A. Garg, J. Hundal, and A. Strunk, Overall and Subgroup Prevalence of Crohn Disease Among Patients With Hidradenitis Suppurativa: A Population-Based Analysis in the United States, JAMA Dermatology. 1 juill, vol.154, issue.7, p.814, 2018.

I. E. Deckers, F. Benhadou, M. J. Koldijk, V. Del-marmol, B. Horváth et al., Inflammatory bowel disease is associated with hidradenitis suppurativa: Results from a multicenter cross-sectional study, Journal of the American Academy of Dermatology. janv, vol.76, issue.1, pp.49-53, 2017.

A. Egeberg, G. Jemec, A. B. Kimball, H. Bachelez, G. H. Gislason et al., Prevalence and Risk of Inflammatory Bowel Disease in Patients with Hidradenitis Suppurativa, Journal of Investigative Dermatology. mai, vol.137, issue.5, pp.1060-1064, 2017.

I. C. Janse, M. J. Koldijk, L. M. Spekhorst, A. V. Vila, R. K. Weersma et al., Identification of Clinical and Genetic Parameters Associated with Hidradenitis Suppurativa in Inflammatory Bowel Disease: Inflammatory Bowel Diseases, janv, vol.22, issue.1, pp.106-119, 2016.

L. M. Dumont, S. Guégan, C. Landman, H. Sokol, L. Beaugerie et al., L'hidradénite suppurée ou maladie de Verneuil influence-t-elle le pronostic de la maladie de Crohn ? Annales de Dermatologie et de Vénéréologie, déc, vol.144, issue.12, p.99, 2017.

H. H. Van-der-zee, C. J. Van-der-woude, E. F. Florencia, and E. P. Prens, Hidradenitis suppurativa and inflammatory bowel disease: are they associated? Results of a pilot study, Br J Dermatol. janv, vol.162, issue.1, pp.195-202, 2010.

J. Braun, M. Bollow, G. Remlinger, U. Eggens, M. Rudwaleit et al., Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors, Arthritis & Rheumatism. janv, vol.41, issue.1, pp.58-67, 1998.

M. Fauconier, Z. Reguiai, C. Barbe, A. Colosio, J. Eschard et al., Association between hidradenitis suppurativa and spondyloarthritis, Joint Bone Spine, vol.85, issue.5, pp.593-600, 2018.

A. Rondags, K. R. Van-straalen, S. Arends, H. H. Van-der-zee, E. P. Prens et al., High prevalence of clinical spondyloarthritis features in patients with hidradenitis suppurativa, Journal of the American Academy of Dermatology. févr, vol.80, issue.2, pp.551-554, 2019.

E. Dauden, P. Lazaro, M. D. Aguilar, A. J. Blasco, C. Suarez et al., Recommendations for the management of comorbidity in hidradenitis suppurativa, Journal of the European Academy of Dermatology and Venereology. janv, vol.32, issue.1, pp.129-173, 2018.

T. Ergun, Hidradenitis suppurativa and the metabolic syndrome, Clinics in Dermatology. janv, vol.36, issue.1, pp.41-48, 2018.

Z. V. Lim and H. H. Oon, Management of Hidradenitis Suppurativa in Patients with Metabolic Comorbidities, Annals of Dermatology, vol.28, issue.2, p.147, 2016.

I. M. Miller, R. J. Mcandrew, and H. I. Prevalence, Risk Factors, and Comorbidities of Hidradenitis Suppurativa, Dermatologic Clinics. janv, vol.34, issue.1, pp.7-16, 2016.

I. M. Miller, C. Ellervik, G. R. Vinding, K. Zarchi, K. S. Ibler et al., Association of metabolic syndrome and hidradenitis suppurativa, JAMA Dermatol. déc, vol.150, issue.12, pp.1273-80, 2014.

D. A. Gold, V. J. Reeder, M. G. Mahan, and I. H. Hamzavi, The prevalence of metabolic syndrome in patients with hidradenitis suppurativa, J Am Acad Dermatol. avr, vol.70, issue.4, pp.699-703, 2014.

J. C. Pascual, I. González, D. Corona, P. Hispán, J. M. Ramos et al., Assessment of subclinical atherosclerosis in hidradenitis suppurativa, J Eur Acad Dermatol Venereol. juill, vol.31, issue.7, pp.1229-1267, 2017.

C. C. Zouboulis, F. G. Bechara, J. L. Dickinson-blok, W. Gulliver, B. Horváth et al., Hidradenitis suppurativa/acne inversa: a practical framework for treatment optimization -systematic review and recommendations from the HS ALLIANCE working group, Journal of the European Academy of Dermatology and Venereology. janv, vol.33, issue.1, pp.19-31, 2019.

J. Lapins, W. Ye, O. Nyrén, and L. Emtestam, Incidence of cancer among patients with hidradenitis suppurativa, Arch Dermatol. juin, vol.137, issue.6, pp.730-734, 2001.

R. Tannenbaum, A. Strunk, and A. Garg, Association Between Hidradenitis Suppurativa and Lymphoma, JAMA Dermatology. 1 mai, vol.155, issue.5, p.624, 2019.

A. Garg, E. Neuren, and A. Strunk, Hidradenitis Suppurativa Is Associated with Polycystic Ovary Syndrome: A PopulationBased Analysis in the United States, J Invest Dermatol, vol.138, issue.6, pp.1288-92, 2018.

Y. T. Melibary, Hidradenitis suppurativa in a patient with hyperandrogenism, insulin-resistance and acanthosis nigricans (HAIR-AN syndrome), Dermatology Reports, vol.25, issue.2018

N. Scheinfeld, An atlas of the morphological manifestations of hidradenitis suppurativa, Dermatol Online J. 16 avr, vol.20, issue.4, p.22373, 2014.

R. F. Spiller and J. M. Knox, Fox-Fordyce disease with hidradenitis suppurativa, J Invest Dermatol. août, vol.31, issue.2, pp.127-162, 1958.

S. D. Resnick, D. F. Murrell, and J. T. Woosley, Pityriasis rubra pilaris, acne conglobata, and elongated follicular spines: an HIVassociated follicular syndrome?, J Am Acad Dermatol. août, vol.29, issue.2, p.283, 1993.

J. Ornelas, R. Sivamani, and S. Awasthi, A Report of Two Patients with Darier Disease and Hidradenitis Suppurativa, Pediatric Dermatology. juill, vol.33, issue.4, pp.265-271, 2016.

M. T. Sahin, S. Oztürkcan, A. Türel-ermertcan, D. Yurtman-havlucu, and C. Bilaç, Behçet's disease associated with hidradenitis suppurativa, J Eur Acad Dermatol Venereol. mars, vol.21, issue.3, pp.428-437, 2007.

G. Sais, C. Admella, M. J. Fantova, and J. C. Montero, Lymphocytic autoimmune hidradenitis, cutaneous leucocytoclastic vasculitis and primary Sjögren's syndrome, Br J Dermatol. déc, vol.139, issue.6, pp.1073-1079, 1998.

R. L. Attanoos, M. A. Appleton, L. E. Hughes, A. Id, D. et al., Granulomatous hidradenitis suppurativa and cutaneous Crohn's disease, Histopathology. août, vol.23, issue.2, pp.111-116, 1993.

H. Müller, K. Eisendle, B. Zelger, and R. Zangerle, Bilateral scrofuloderma of the axilla masquerading as hidradenitis suppurativa, Acta Derm Venereol, vol.88, issue.6, pp.629-659, 2008.

X. Wortsman, J. Revuz, and G. Jemec, Lymph nodes in hidradenitis suppurativa, Dermatology (Basel), vol.219, issue.1, pp.22-26, 2009.

O. Faye, F. Petit, F. Poli, T. Petit, J. Wechsler et al.,

, Ann Dermatol Venereol. juill, vol.134, issue.6-7, pp.567-576, 2007.

C. Constantinou, K. Widom, J. Desantis, and M. Obmann, Hidradenitis suppurativa complicated by squamous cell carcinoma, Am Surg. déc, vol.74, issue.12, pp.1177-81, 2008.

C. Lavogiez, E. Delaporte, S. Darras-vercambre, M. De-lassalle, E. Castillo et al., Clinicopathological Study of 13 Cases of Squamous Cell Carcinoma Complicating Hidradenitis Suppurativa, Dermatology, vol.220, issue.2, pp.147-53, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00486365

N. Jourabchi, A. H. Fischer, A. Cimino-mathews, K. M. Waters, and G. A. Okoye, Squamous cell carcinoma complicating a chronic lesion of hidradenitis suppurativa: a case report and review of the literature: Squamous cell carcinoma complicating a chronic lesion of hidradenitis suppurativa, International Wound Journal. avr, vol.14, issue.2, pp.435-443, 2017.

C. Yen, Y. Chang, and Y. Lee, Image Gallery: Squamous cell carcinoma arising in long-standing hidradenitis suppurativa, British Journal of Dermatology. déc, vol.179, issue.6, pp.226-226, 2018.

I. E. Deckers, H. H. Van-der-zee, and E. P. Prens, Severe fatigue based on anaemia in patients with hidradenitis suppurativa: report of two cases and a review of the literature, Journal of the European Academy of Dermatology and Venereology. janv, vol.30, issue.1, pp.174-179, 2016.

K. D. Schandorff, I. M. Miller, D. Krustrup, G. Jemec, and P. Marckmann, Renal amyloid A amyloidosis as a complication of hidradenitis suppurativa, Clin Nephrol. juill, vol.86, issue.1, pp.51-55, 2016.

X. Wortsman, C. Moreno, R. Soto, J. Arellano, C. Pezo et al., Ultrasound In-Depth Characterization and Staging of Hidradenitis Suppurativa: Dermatologic Surgery, déc, vol.39, issue.12, pp.1835-1877, 2013.

X. Wortsman, Imaging of Hidradenitis Suppurativa, Dermatologic Clinics. janv, vol.34, issue.1, pp.59-68, 2016.

N. Griffin, A. B. Williams, S. Anderson, P. M. Irving, J. Sanderson et al., Hidradenitis Suppurativa: MRI Features in Anogenital Disease, Diseases of the Colon & Rectum. juin, vol.57, issue.6, pp.762-71, 2014.

L. Monnier, A. Dohan, N. Amara, A. Zagdanski, M. Drame et al., Anoperineal disease in Hidradenitis Suppurativa : MR imaging distinction from perianal Crohn's disease. European Radiology, vol.27, pp.4100-4109, 2017.

H. Guet-revillet, H. Coignard-biehler, J. Jais, G. Quesne, E. Frapy et al., Bacterial pathogens associated with hidradenitis suppurativa, France. Emerging Infect Dis. déc, vol.20, issue.12, pp.1990-1998, 2014.

H. Guet-revillet, J. Jais, M. Ungeheuer, H. Coignard-biehler, S. Duchatelet et al., The Microbiological Landscape of Anaerobic Infections in Hidradenitis Suppurativa: A Prospective Metagenomic Study, Clinical Infectious Diseases. 15 juill, vol.65, issue.2, pp.282-91, 2017.

D. D. Rhoads, R. D. Wolcott, Y. Sun, and S. E. Dowd, Comparison of culture and molecular identification of bacteria in chronic wounds, Int J Mol Sci, vol.13, issue.3, pp.2535-50, 2012.

D. D. Rhoads, S. B. Cox, E. J. Rees, Y. Sun, and R. D. Wolcott, Clinical identification of bacteria in human chronic wound infections: culturing vs. 16S ribosomal DNA sequencing, BMC Infect Dis, vol.12, p.321, 2012.

T. R. Thomsen, M. S. Aasholm, V. B. Rudkjøbing, A. M. Saunders, T. Bjarnsholt et al., The bacteriology of chronic venous leg ulcer examined by culture-independent molecular methods, Wound Repair Regen. févr, vol.18, issue.1, 2010.

. Verneuil, Etudes sur les tumeurs de la peau, de quelques maladies des glandes sudoripares. Archives générales de médecine, 1854, tome, vol.4, pp.447-468

W. P. Morgan and L. E. Hughes, The distribution, size and density of the apocrine glands in hidradenitis suppurativa, Br J Surg, vol.66, issue.12, pp.853-859, 1979.

C. C. Yu and M. G. Cook, Hidradenitis suppurativa: a disease of follicular epithelium, rather than apocrine glands, Br J Dermatol. juin, vol.122, issue.6, pp.763-772, 1990.

J. Boer and E. F. Weltevreden, Hidradenitis suppurativa or acne inversa. A clinicopathological study of early lesions, Br J Dermatol. nov, vol.135, issue.5, pp.721-726, 1996.

G. B. Jemec and U. Hansen, Histology of hidradenitis suppurativa, J Am Acad Dermatol. juin, vol.34, issue.6, pp.994-1003, 1996.

G. B. Jemec, B. M. Thomsen, and U. Hansen, The homogeneity of hidradenitis suppurativa lesions. A histological study of intra-individual variation, APMIS. mai, vol.105, issue.5, pp.378-83, 1997.

G. B. Jemec, M. Faber, E. Gutschik, and P. Wendelboe, The bacteriology of hidradenitis suppurativa, Dermatology (Basel), vol.193, issue.3, pp.203-209, 1996.

H. C. Ring, R. Mikkelsen, P. Miller, I. M. Jenssen, H. Fuursted et al., The bacteriology of hidradenitis suppurativa: a systematic review, Exp Dermatol. oct, vol.24, issue.10, pp.727-758, 2015.

J. Lapins, C. Jarstrand, and L. Emtestam, Coagulase-negative staphylococci are the most common bacteria found in cultures from the deep portions of hidradenitis suppurativa lesions, as obtained by carbon dioxide laser surgery, Br J Dermatol. janv, vol.140, issue.1, pp.90-95, 1999.

A. S. Highet, R. E. Warren, R. C. Staughton, and S. O. Roberts, Streptococcus milleri causing treatable infection in perineal hidradenitis suppurativa, Br J Dermatol. oct, vol.103, issue.4, pp.375-82, 1980.

H. C. Ring, V. Sigsgaard, J. Thorsen, K. Fuursted, S. Fabricius et al., The microbiome of tunnels in hidradenitis suppurativa patients, J Eur Acad Dermatol Venereol. 25 mars, 2019.

H. C. Ring, L. Bay, M. Nilsson, K. Kallenbach, I. M. Miller et al., Bacterial biofilm in chronic lesions of hidradenitis suppurativa, British Journal of Dermatology. avr, vol.176, issue.4, pp.993-1000, 2017.

C. Hotz, M. Boniotto, A. Guguin, M. Surenaud, F. Jean-louis et al., Intrinsic Defect in Keratinocyte Function Leads to Inflammation in Hidradenitis Suppurativa, Journal of Investigative Dermatology. sept, vol.136, issue.9, pp.1768-80, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01406612

R. E. Hunger, A. M. Surovy, A. S. Hassan, L. R. Braathen, and N. Yawalkar, Toll-like receptor 2 is highly expressed in lesions of acne inversa and colocalizes with C-type lectin receptor, British Journal of Dermatology. avr, vol.158, issue.4, pp.691-698, 2008.

K. Wolk, K. Warszawska, C. Hoeflich, E. Witte, S. Schneider-burrus et al., Deficiency of IL-22 contributes to a chronic inflammatory disease: pathogenetic mechanisms in acne inversa, J Immunol. 15 janv, vol.186, issue.2, pp.1228-1267, 2011.

B. Dréno, Hidradenitis Suppurativa: The Role of Deficient Cutaneous Innate Immunity, Archives of Dermatology. 1 févr, vol.148, issue.2, p.182, 2012.

E. Mozeika, M. Pilmane, B. M. Nürnberg, and G. Jemec, Tumour necrosis factor-alpha and matrix metalloproteinase-2 are expressed strongly in hidradenitis suppurativa, Acta Derm Venereol. mai, vol.93, issue.3, pp.301-305, 2013.

F. G. Bechara, M. Sand, M. Skrygan, A. Kreuter, P. Altmeyer et al., Acne inversa: evaluating antimicrobial peptides and proteins, Ann Dermatol, vol.24, issue.4, pp.393-400, 2012.

G. Kelly, R. Hughes, T. Mcgarry, M. Van-den-born, K. Adamzik et al., Dysregulated cytokine expression in lesional and nonlesional skin in hidradenitis suppurativa, Br J Dermatol. déc, vol.173, issue.6, pp.1431-1440, 2015.

V. U. Emelianov, F. G. Bechara, R. Gläser, E. A. Langan, W. M. Taungjaruwinai et al., Immunohistological pointers to a possible role for excessive cathelicidin (LL-37) expression by apocrine sweat glands in the pathogenesis of hidradenitis suppurativa/acne inversa, Br J Dermatol. mai, vol.166, issue.5, pp.1023-1057, 2012.

C. Schlapbach, T. Hänni, N. Yawalkar, and R. E. Hunger, Expression of the IL-23/Th17 pathway in lesions of hidradenitis suppurativa, J Am Acad Dermatol, vol.65, issue.4, pp.790-798, 2011.

H. H. Van-der-zee, L. De-ruiter, D. G. Van-den-broecke, W. A. Dik, J. D. Laman et al., Elevated levels of tumour necrosis factor (TNF)-?, interleukin (IL)-1? and IL-10 in hidradenitis suppurativa skin: a rationale for targeting TNF-? and IL-1?, Br J Dermatol. juin, vol.164, issue.6, pp.1292-1300, 2011.

J. W. Frew, D. A. Vekic, J. Woods, and G. D. Cains, A systematic review and critical evaluation of reported pathogenic sequence variants in hidradenitis suppurativa, Br J Dermatol, vol.177, issue.4, pp.987-98, 2017.

C. P. Lu, L. Polak, A. S. Rocha, H. A. Pasolli, S. Chen et al., Identification of stem cell populations in sweat glands and ducts reveals roles in homeostasis and wound repair, Cell. 6 juill, vol.150, issue.1, pp.136-50, 2012.

L. Rittié, D. L. Sachs, J. S. Orringer, J. J. Voorhees, and G. J. Fisher, Eccrine sweat glands are major contributors to reepithelialization of human wounds, Am J Pathol. janv, vol.182, issue.1, pp.163-71, 2013.

B. Schittek, R. Hipfel, B. Sauer, J. Bauer, H. Kalbacher et al., Dermcidin: a novel human antibiotic peptide secreted by sweat glands, Nat Immunol. déc, vol.2, issue.12, pp.1133-1140, 2001.

X. Dai, H. Okazaki, Y. Hanakawa, M. Murakami, M. Tohyama et al., Eccrine sweat contains IL-1?, IL-1? and IL-31 and activates epidermal keratinocytes as a danger signal, PLoS ONE, vol.8, issue.7, p.67666, 2013.

M. Coates, P. Mariottoni, D. L. Corcoran, H. F. Kirshner, T. Jaleel et al., The skin transcriptome in hidradenitis suppurativa uncovers an antimicrobial and sweat gland gene signature which has distinct overlap with wounded skin, Blumenberg M, éditeur. PLOS ONE. 6 mai, vol.14, issue.5, p.216249, 2019.

B. Wang, W. Yang, W. Wen, J. Sun, B. Su et al., Gamma-secretase gene mutations in familial acne inversa, Science, vol.330, issue.6007, p.1065, 2010.

A. E. Pink, M. A. Simpson, N. Desai, R. C. Trembath, and J. Barker, ?-Secretase mutations in hidradenitis suppurativa: new insights into disease pathogenesis, J Invest Dermatol. mars, vol.133, issue.3, pp.601-608, 2013.

A. V. Marzano, V. Trevisan, M. Gattorno, I. Ceccherini, D. Simone et al., Pyogenic arthritis, pyoderma gangrenosum, acne, and hidradenitis suppurativa (PAPASH): a new autoinflammatory syndrome associated with a novel mutation of the PSTPIP1 gene, JAMA Dermatol. juin, vol.149, issue.6, pp.762-766, 2013.

S. Duchatelet, S. Miskinyte, O. Join-lambert, M. Ungeheuer, C. Francès et al., First nicastrin mutation in PASH (pyoderma gangrenosum, acne and suppurative hidradenitis) syndrome, Br J Dermatol. août, vol.173, issue.2, pp.610-612, 2015.

X. Calderón-castrat, D. Bancalari-díaz, C. Román-curto, A. Romo-melgar, D. Amorós-cerdán et al., PSTPIP1 gene mutation in a pyoderma gangrenosum, acne and suppurative hidradenitis (PASH) syndrome, Br J Dermatol. juill, vol.175, issue.1, pp.194-202, 2016.

A. Garg and A. Strunk, Risk of Alzheimer's disease is not increased among patients with hidradenitis suppurativa: A retrospective population-based cohort analysis, J Am Acad Dermatol, vol.77, issue.1, pp.176-183, 2017.

P. Theut-riis, A. Egeberg, G. H. Gislason, and G. B. Jemec, Patients with hidradenitis suppurativa have no increased risk of Alzheimer disease, Br J Dermatol, vol.177, issue.1, pp.273-278, 2017.

I. Karagiannidis, G. Nikolakis, R. Sabat, and C. C. Zouboulis, Hidradenitis suppurativa/Acne inversa: an endocrine skin disorder?, Rev Endocr Metab Disord, vol.17, issue.3, pp.335-376, 2016.

I. Karagiannidis, G. Nikolakis, and C. C. Zouboulis, Endocrinologic Aspects of Hidradenitis Suppurativa, Dermatologic Clinics. janv, vol.34, issue.1, pp.45-54, 2016.

A. Vossen, K. R. Van-straalen, E. P. Prens, and H. H. Van-der-zee, Menses and pregnancy affect symptoms in hidradenitis suppurativa: A cross-sectional study, Journal of the American Academy of Dermatology. janv, vol.76, issue.1, pp.155-161, 2017.

P. T. Riis, H. C. Ring, L. Themstrup, and G. B. Jemec, The Role of Androgens and Estrogens in Hidradenitis Suppurativa -A Systematic Review, Acta Dermatovenerol Croat. déc, vol.24, issue.4, pp.239-288, 2016.

A. K. Clark, R. L. Quinonez, S. Saric, and R. K. Sivamani, Hormonal therapies for hidradenitis suppurativa: Review, Dermatology Online Journal, vol.23, issue.10, p.7, 2017.

G. Kelly and E. P. Prens, Inflammatory Mechanisms in Hidradenitis Suppurativa, Dermatol Clin. janv, vol.34, issue.1, pp.51-59, 2016.

S. Yazdanyar and G. Jemec, Hidradenitis suppurativa: a review of cause and treatment, Curr Opin Infect Dis. avr, vol.24, issue.2, pp.118-141, 2011.

R. Sabat, A. Chanwangpong, S. Schneider-burrus, D. Metternich, G. Kokolakis et al., Increased Prevalence of Metabolic Syndrome in Patients with Acne Inversa. Bruggemann H, éditeur, PLoS ONE. 16 févr, vol.7, issue.2, p.31810, 2012.

A. Vossen, H. H. Van-der-zee, and E. P. Prens, Hidradenitis Suppurativa: A Systematic Review Integrating Inflammatory Pathways Into a Cohesive Pathogenic Model. Frontiers in Immunology, vol.14

H. C. Ring, T. Riis, P. Miller, I. M. Saunte, D. M. Jemec et al., Self-reported pain management in hidradenitis suppurativa, British Journal of Dermatology. avr, vol.174, issue.4, pp.909-920, 2016.

B. Horváth, I. C. Janse, and G. R. Sibbald, Pain management in patients with hidradenitis suppurativa, Journal of the American Academy of Dermatology, vol.73, issue.5, pp.47-51, 2015.

P. Wolkenstein, A. Loundou, K. Barrau, P. Auquier, and J. Revuz, Quality of life impairment in hidradenitis suppurativa: A study of 61 cases, Journal of the American Academy of Dermatology. avr, vol.56, issue.4, pp.621-624, 2007.

A. J. Onderdijk, H. H. Van-der-zee, S. Esmann, S. Lophaven, D. N. Dufour et al., Depression in patients with hidradenitis suppurativa: Depression in HS patients, Journal of the European Academy of Dermatology and Venereology. avr, vol.27, issue.4, pp.473-481, 2013.

?. Matusiak, A. Bieniek, and J. C. Szepietowski, Hidradenitis suppurativa markedly decreases quality of life and professional activity, Journal of the American Academy of Dermatology. avr, vol.62, issue.4, pp.706-708, 2010.

I. H. Hamzavi, M. Sundaram, C. Nicholson, M. Zivkovic, A. Parks-miller et al., Uncovering burden disparity: A comparative analysis of the impact of moderate-to-severe psoriasis and hidradenitis suppurativa, Journal of the American Academy of Dermatology. déc, vol.77, issue.6, pp.1038-1084, 2017.

?. Matusiak, A. Bieniek, and J. Szepietowski, Psychophysical Aspects of Hidradenitis Suppurativa, Acta Dermato Venereologica, vol.90, issue.3, pp.264-272, 2010.

S. Esmann and G. Jemec, Psychosocial Impact of Hidradenitis Suppurativa: A Qualitative Study, Acta Dermato Venereologica, vol.91, issue.3, pp.328-360, 2011.

S. Schneider-burrus, A. Jost, E. Peters, E. Witte-haendel, W. Sterry et al., Association of Hidradenitis Suppurativa With Body Image, JAMA Dermatology. 1 avr, vol.154, issue.4, p.447, 2018.

T. Tzellos, H. Yang, F. Mu, B. Calimlim, and J. Signorovitch, Impact of hidradenitis suppurativa on work loss, indirect costs and income, British Journal of Dermatology, issue.22, 2018.

D. Sur,

A. Alikhan, P. J. Lynch, and D. B. Eisen, Hidradenitis suppurativa: A comprehensive review, Journal of the American Academy of Dermatology. avr, vol.60, issue.4, pp.539-61, 2009.

A. Kurek, E. Peters, A. Chanwangpong, R. Sabat, W. Sterry et al., Profound disturbances of sexual health in patients with acne inversa, Journal of the American Academy of Dermatology. sept, vol.67, issue.3, pp.422-428, 2012.

I. C. Janse, I. E. Deckers, A. D. Van-der-maten, A. Evers, J. Boer et al., Sexual health and quality of life are impaired in hidradenitis suppurativa: a multicentre cross-sectional study, British Journal of Dermatology. avr, vol.176, issue.4, pp.1042-1049, 2017.

C. Cuenca-barrales, R. Ruiz-villaverde, and A. Molina-leyva, Sexual Distress in Patients with Hidradenitis Suppurativa: A Cross-Sectional Study, Journal of Clinical Medicine. 18 avr, vol.8, issue.4, p.532, 2019.

A. Alavi, D. Farzanfar, T. Rogalska, M. A. Lowes, and S. Chavoshi, Quality of life and sexual health in patients with hidradenitis suppurativa, International Journal of Women's Dermatology. juin, vol.4, issue.2, pp.74-83, 2018.

F. Sampogna, D. Abeni, U. Gieler, L. Tomas-aragones, L. L. Titeca et al., , vol.3, p.485

, Dermatological Outpatients From a Multicentre Study in 13 European Countries, Acta Dermato Venereologica, vol.97, issue.4, pp.478-82, 2017.

M. Sisic, J. Tan, and K. D. Lafreniere, Hidradenitis Suppurativa, Intimate Partner Violence, and Sexual Assault, Journal of Cutaneous Medicine and Surgery. sept, vol.21, issue.5, pp.383-390, 2017.

A. Kurek, J. Peters, E. M. Sabat, R. Sterry, W. Schneider-burrus et al., Depression is a frequent co-morbidity in patients with acne inversa: Acne inversa and depression, JDDG: Journal der Deutschen Dermatologischen Gesellschaft. août, vol.11, issue.8, pp.743-752, 2013.

E. Shavit, J. Dreiher, T. Freud, S. Halevy, S. Vinker et al., Psychiatric comorbidities in 3207 patients with hidradenitis suppurativa, Journal of the European Academy of Dermatology and Venereology. févr, vol.29, issue.2, pp.371-377, 2015.

J. J. Crowley, J. R. Mekkes, C. C. Zouboulis, N. Scheinfeld, A. Kimball et al., Association of hidradenitis suppurativa disease severity with increased risk for systemic comorbidities, British Journal of Dermatology. déc, vol.171, issue.6, pp.1561-1566, 2014.

L. Thorlacius, A. D. Cohen, G. H. Gislason, G. Jemec, and A. Egeberg, Increased Suicide Risk in Patients with Hidradenitis Suppurativa, Journal of Investigative Dermatology. janv, vol.138, issue.1, pp.52-59, 2018.

H. Tiri, L. Huilaja, J. Jokelainen, M. Timonen, and K. Tasanen, Women with Hidradenitis Suppurativa Have an Elevated Risk of Suicide, Journal of Investigative Dermatology. déc, vol.138, issue.12, pp.2672-2676, 2018.

L. A. Mcwilliams, B. J. Cox, and M. W. Enns, Mood and anxiety disorders associated with chronic pain: an examination in a nationally representative sample. Pain, vol.106, pp.127-160, 2003.

K. R. Patel, S. Rastogi, V. Singam, H. H. Lee, A. Z. Amin et al., Association between hidradenitis suppurativa and hospitalization for psychiatric disorders: a cross-sectional analysis of the National Inpatient Sample, British Journal of Dermatology, vol.26, issue.2019

D. Sur,

L. Huilaja, H. Tiri, J. Jokelainen, M. Timonen, and K. Tasanen, Patients with Hidradenitis Suppurativa Have a High Psychiatric Disease Burden: A Finnish Nationwide Registry Study, Journal of Investigative Dermatology. janv, vol.138, issue.1, pp.46-51, 2018.

A. Garg, V. Papagermanos, M. Midura, A. Strunk, and J. Merson, Opioid, alcohol, and cannabis misuse among patients with hidradenitis suppurativa: A population-based analysis in the United States, Journal of the American Academy of Dermatology. sept, vol.79, issue.3, pp.495-500, 2018.

C. Lesort, A. P. Villani, J. Giai, P. A. Becherel, J. Delaunay et al., High prevalence of cannabis use among patients with hidradenitis suppurativa: results from the VERADDICT survey, British Journal of Dermatology

D. Sur,

A. Alikhan, C. Sayed, A. Alavi, R. Alhusayen, A. Brasasard et al., North American Clinical Management Guidelines for Hidradenitis Suppurativa: a Publication from the United States and Canadian Hidradenitis Suppurativa Foundations. Part II: Topical, Intralesional, and Systemic medical Management, Journal of the American Academy of Dermatology

D. Sur,

J. R. Ingram, F. Collier, D. Brown, T. Burton, J. Burton et al., British Association of Dermatologists guidelines for the management of hidradenitis suppurativa (acne inversa) 2018, British Journal of Dermatology, vol.15, issue.2018

D. Sur,

G. Nazzaro, R. Zerboni, E. Passoni, M. Barbareschi, A. V. Marzano et al., High-frequency ultrasound in hidradenitis suppurativa as rationale for permanent hair laser removal. Skin Research and Technology

D. Sur,

D. Saunte and G. Jemec, Hidradenitis Suppurativa: Advances in Diagnosis and Treatment, JAMA, vol.318, issue.20, p.2019, 2017.

L. Jennings, R. Hambly, R. Hughes, B. Moriarty, and B. Kirby, Metformin use in hidradenitis suppurativa, Journal of Dermatological Treatment. 20 mars, pp.1-3, 2019.

R. Verdolini, N. Clayton, A. Smith, N. Alwash, and B. Mannello, Metformin for the treatment of hidradenitis suppurativa: a little help along the way: Metformin for the treatment of hidradenitis suppurativa, Journal of the European Academy of Dermatology and Venereology. sept, vol.27, issue.9, pp.1101-1109, 2013.

B. N. Khandalavala, A Disease-Modifying Approach for Advanced Hidradenitis Suppurativa (Regimen with Metformin, Liraglutide, Dapsone, and Finasteride): A Case Report, Case Reports in Dermatology. 13 juill, pp.70-78, 2017.

L. Jennings, L. Nestor, O. Molloy, R. Hughes, B. Moriarty et al., The treatment of hidradenitis suppurativa with the glucagon-like peptide-1 agonist liraglutide, British Journal of Dermatology. sept, vol.177, issue.3, pp.858-867, 2017.

A. Alavi and R. S. Kirsner, Local wound care and topical management of hidradenitis suppurativa, Journal of the American Academy of Dermatology, vol.73, issue.5, pp.55-61, 2015.

A. Alavi, R. G. Sibbald, and R. S. Kirsner, Optimal hidradenitis suppurativa topical treatment and wound care management: a revised algorithm, Journal of Dermatological Treatment. 19 mai, vol.29, issue.4, pp.383-387, 2018.

J. Boer and G. Jemec, Resorcinol peels as a possible self-treatment of painful nodules in hidradenitis suppurativa: Resorcinol peels as a possible self-treatment of painful nodules in HS, Clinical and Experimental Dermatology. janv, vol.35, issue.1, pp.36-40, 2010.

J. C. Pascual, B. Encabo, R. F. Ruiz-de-apodaca, D. Romero, J. Selva et al., Topical 15% resorcinol for hidradenitis suppurativa: An uncontrolled prospective trial with clinical and ultrasonographic follow-up, Journal of the American Academy of Dermatology. déc, vol.77, issue.6, pp.1175-1183, 2017.

N. Cassano, G. Alessandrini, M. Mastrolonardo, and G. A. Vena, Peeling agents: toxicological and allergological aspects, J Eur Acad Dermatol Venereol, vol.10, 1999.

O. J. Clemmensen, Topical Treatment of Hidradenitis Suppurativa with Clindamycin, International Journal of Dermatology. juin, vol.22, issue.5, pp.325-333, 1983.

G. Jemec and P. Wendelboe, Topical clindamycin versus systemic tetracycline in the treatment of hidradenitis suppurativa, Journal of the American Academy of Dermatology. déc, vol.39, issue.6, pp.971-975, 1998.

P. T. Riis, J. Boer, E. P. Prens, D. Saunte, I. E. Deckers et al., Intralesional triamcinolone for flares of hidradenitis suppurativa (HS): A case series, Journal of the American Academy of Dermatology. déc, vol.75, issue.6, pp.1151-1156, 2016.

K. Fajenbaum, Intralesional triamcinolone, a standard of care treatment for acute hidradenitis suppurativa, does not prove to be superior to placebo, 2nd annual symposium on hidradenitis suppurativa, Hotel, pp.4-5, 2017.

D. J. O'reilly, J. M. Pleat, and A. M. Richards, Treatment of hidradenitis suppurativa with botulinum toxin A. Plast Reconstr Surg, vol.116, pp.1575-1581, 2005.

A. Khoo and E. P. Burova, Hidradenitis suppurativa treated with Clostridium botulinum toxin A, Clinical and Experimental Dermatology. août, vol.39, issue.6, pp.749-50, 2014.

A. Campanati, E. Martina, K. Giuliodori, I. Bobyr, V. Consales et al., Two cases of Hidradenitis suppurativa and botulinum toxin type a therapy: A novel approach for a pathology that is still difficult to manage, Dermatologic Therapy. 10 févr, 2019.

W. Shi, S. Schultz, A. Strouse, and D. R. Gater, Successful treatment of stage III hidradenitis suppurativa with botulinum toxin A, BMJ Case Reports. janv, vol.12, issue.1, p.226064, 2019.

G. Gener, F. Canoui-poitrine, J. E. Revuz, F. O. Poli, F. Gabison et al., Combination Therapy with Clindamycin and Rifampicin for Hidradenitis Suppurativa: A Series of 116 Consecutive Patients, Dermatology, vol.219, issue.2, pp.143-150, 2009.

V. Bettoli, S. Zauli, A. Borghi, G. Toni, S. Minghetti et al., Oral clindamycin and rifampicin in the treatment of hidradenitis suppurativa-acne inversa: a prospective study on 23 patients, Journal of the European Academy of Dermatology and Venereology. janv, vol.28, issue.1, pp.125-131, 2014.

C. Caro, R. D. Cannizzaro, M. V. Botti, E. , D. Raimondo et al., Clindamycin versus clindamycin plus rifampicin in hidradenitis suppurativa treatment: Clinical and ultrasound observations, Journal of the American Academy of Dermatology. mai, vol.80, issue.5, pp.1314-1335, 2019.

O. Join-lambert, F. Ribadeau-dumas, V. Jullien, M. Kitzis, J. Jais et al., Dramatic reduction of clindamycin plasma concentration in hidradenitis suppurativa patients treated with the rifampin-clindamycin combination, European Journal of Dermatology, vol.24, issue.1, pp.94-99, 2014.

P. Mendes-bastos, R. Macedo, and R. Duarte, Treatment of hidradenitis suppurativa with rifampicin: have we forgotten tuberculosis?, British Journal of Dermatology, vol.177, issue.4, pp.150-151, 2017.

S. Hem, M. Delage, A. Nassif, and O. Join-lambert, Antimicrobial resistance of anaerobic actinomycetes: a retrospective monocentric study focusing on hidradenitis suppurativa. Presented at the 6th Conference of the European Hidradenitis Suppurativa Foundation, 2017.

J. Delaunay, A. P. Villani, P. Guillem, A. Tristan, A. Boibieux et al., Oral ofloxacin and clindamycin as an alternative to the classic rifampicin-clindamycin in hidradenitis suppurativa: retrospective analysis of 65 patients, British Journal of Dermatology. janv, vol.178, issue.1, pp.15-21, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01953694

O. Join-lambert, H. Coignard, J. Jais, H. Guet-revillet, S. Poirée et al., Efficacy of Rifampin-MoxifloxacinMetronidazole Combination Therapy in Hidradenitis Suppurativa, Dermatology, vol.222, issue.1, pp.49-58, 2011.

O. Join-lambert, H. Coignard-biehler, J. Jais, M. Delage, H. Guet-revillet et al., Efficacy of ertapenem in severe hidradenitis suppurativa: a pilot study in a cohort of 30 consecutive patients, Journal of Antimicrobial Chemotherapy. févr, vol.71, issue.2, pp.513-533, 2016.

C. O. Mendonca and C. Griffiths, Clindamycin and rifampicin combination therapy for hidradenitis suppurativa, British Journal of Dermatology. mai, vol.154, issue.5, pp.977-985, 2006.

C. Dessinioti, C. Zisimou, V. Tzanetakou, A. Stratigos, and C. Antoniou, Oral clindamycin and rifampicin combination therapy for hidradenitis suppurativa: a prospective study and 1-year follow-up, Clinical and Experimental Dermatology. déc, vol.41, issue.8, pp.852-859, 2016.

H. Ochi, L. Tan, and H. Oon, The effect of oral clindamycin and rifampicin combination therapy in patients with hidradenitis suppurativa in Singapore. Clinical, Cosmetic and Investigational Dermatology, janv, vol.11, pp.37-46, 2018.

E. Rosi, L. Pescitelli, F. Ricceri, D. Cesare, A. Novelli et al., Clindamycin as unique antibiotic choice in Hidradenitis Suppurativa, Dermatologic Therapy. mars, vol.32, issue.2, p.12792, 2019.

T. L. Braunberger, N. T. Nartker, C. L. Nicholson, A. F. Nahhas, A. Parks-miller et al., Ertapenem -a potent treatment for clinical and quality of life improvement in patients with hidradenitis suppurativa, International Journal of Dermatology. sept, vol.57, issue.9, pp.1088-93, 2018.

D. G. Abirached, D. S. Barbarot, D. O. Bayrou, D. E. Bourrat, D. S. Dahan et al., , vol.16, 2018.

J. Boer, Long-term results of isotretinoin in the treatment of 68 patients with hidradenitis suppurativa, Journal of the American Academy of Dermatology, vol.4, 1999.

A. Soria, F. Canoui-poitrine, P. Wolkenstein, F. Poli, G. Gabison et al., Absence of Efficacy of Oral Isotretinoin in Hidradenitis Suppurativa: A Retrospective Study Based on Patients' Outcome Assessment, Dermatology, vol.218, issue.2, pp.134-139, 2009.

J. Boer and M. Nazary, Long-term results of acitretin therapy for hidradenitis suppurativa. Is acne inversa also a misnomer?: Long-term acitretin for HS, British Journal of Dermatology. janv, vol.164, issue.1, pp.170-175, 2011.

N. Puri and A. Talwar, A study on the management of hidradenitis suppurativa with retinoids and surgical excision, Indian J Dermatol, vol.56, issue.6, pp.650-651, 2011.

M. G. Tan, N. H. Shear, S. Walsh, and R. Alhusayen, Acitretin: Monotherapy or Combined Therapy for Hidradenitis Suppurativa?, Journal of Cutaneous Medicine and Surgery. janv, vol.21, issue.1, pp.48-53, 2017.

R. Verdolini, F. Simonacci, S. Menon, P. Pavlou, and B. Mannello, Alitretinoin: a useful agent in the treatment of hidradenitis suppurativa, especially in women of child-bearing age, G Ital Dermatol Venereol. avr, vol.150, issue.2, pp.155-62, 2015.

J. Boer, Oral retinoids for hidradenitis suppurativa, Hidradenitis suppurativa, vol.1, pp.150-160

P. S. Mortimer, R. P. Dawber, M. A. Gales, and R. A. Moore, A double-blind controlled cross-over trial of cyproterone acetate in females with hidradenitis suppurativa, Br J Dermatol. sept, vol.115, issue.3, pp.263-271, 1986.

A. J. Stellon and M. Wakeling, Hidradenitis suppurativa associated with use of oral contraceptives, BMJ. 7 janv, vol.298, issue.6665, pp.28-37, 1989.

R. S. Sawers, V. A. Randall, and F. J. Ebling, Control of hidradenitis suppurativa in women using combined antiandrogen (cyproterone acetate) and oestrogen therapy, Br J Dermatol. sept, vol.115, issue.3, pp.269-74, 1986.

J. N. Kraft and G. E. Searles, Hidradenitis suppurativa in 64 female patients: retrospective study comparing oral antibiotics and antiandrogen therapy, J Cutan Med Surg. août, vol.11, issue.4, pp.125-156, 2007.

A. M. Farrell, V. A. Randall, T. Vafaee, and R. P. Dawber, Finasteride as a therapy for hidradenitis suppurativa, Br J Dermatol. déc, vol.141, issue.6, pp.1138-1147, 1999.

M. A. Joseph, E. Jayaseelan, B. Ganapathi, and J. Stephen, Hidradenitis suppurativa treated with finasteride, J Dermatolog Treat. avr, vol.16, issue.2, pp.75-83, 2005.

C. Doménech, J. Matarredona, J. C. Escribano-stablé, J. P. Devesa, J. Vicente et al., Facial Hidradenitis Suppurativa in a 28-Year-Old Male Responding to Finasteride, Dermatology, vol.224, issue.4, pp.307-315, 2012.

A. Lee and G. Fischer, A case series of 20 women with hidradenitis suppurativa treated with spironolactone, Australas J Dermatol. août, vol.56, issue.3, pp.192-198, 2015.

A. Brocard, A. Knol, A. Khammari, and B. Dréno, Hidradenitis Suppurativa and Zinc: A New Therapeutic Approach, Dermatology, vol.214, issue.4, pp.325-332, 2007.

S. Hessam, M. Sand, N. M. Meier, T. Gambichler, L. Scholl et al., Combination of oral zinc gluconate and topical triclosan: An anti-inflammatory treatment modality for initial hidradenitis suppurativa, Journal of Dermatological Science, vol.84, issue.2, pp.197-202, 2016.

S. Yazdanyar, J. Boer, G. Ingvarsson, J. C. Szepietowski, and G. Jemec, Dapsone Therapy for Hidradenitis Suppurativa: A Series of 24 Patients, Dermatology, vol.222, issue.4, pp.342-348, 2011.

M. R. Kaur and H. M. Lewis, Hidradenitis suppurativa treated with dapsone: A case series of five patients, Journal of Dermatological Treatment. janv, vol.17, issue.4, pp.211-214, 2006.

T. Hofer and P. H. Itin,

. Hautarzt, , vol.52, pp.989-92, 2001.

, 254. van der Zee HH, Prens EP. The Anti-Inflammatory Drug Colchicine Lacks Efficacy in Hidradenitis Suppurativa, British National Formulary. Dapsone. 63, vol.223, pp.169-73, 2011.

K. Armyra, A. Kouris, V. Markantoni, A. Katsambas, and G. Kontochristopoulos, Hidradenitis suppurativa treated with tetracycline in combination with colchicine: a prospective series of 20 patients, International Journal of Dermatology. mars, vol.56, issue.3, pp.346-50, 2017.

A. K. Gupta, C. N. Ellis, B. J. Nickoloff, M. T. Goldfarb, V. C. Ho et al., Oral cyclosporine in the treatment of inflammatory and noninflammatory dermatoses. A clinical and immunopathologic analysis, Arch Dermatol. mars, vol.126, issue.3, pp.339-50, 1990.

D. A. Buckley and S. Rogers, Cyclosporin-responsive hidradenitis suppurativa, J R Soc Med. mai, vol.88, issue.5, pp.289-290, 1995.

R. F. Rose, M. Goodfield, and S. M. Clark, Treatment of recalcitrant hidradenitis suppurativa with oral ciclosporin, Clinical and Experimental Dermatology. janv, vol.31, issue.1, pp.154-159, 2006.

L. Bianchi, K. Hansel, and L. Stingeni, Recalcitrant severe hidradenitis suppurativa successfully treated with cyclosporine A, Journal of the American Academy of Dermatology. déc, vol.67, issue.6, pp.278-287, 2012.

M. D. Anderson, S. Zauli, V. Bettoli, J. Boer, and G. Jemec, Cyclosporine treatment of severe Hidradenitis suppurativa -A case series, Journal of Dermatological Treatment. 3 mai, vol.27, issue.3, pp.247-50, 2016.

E. Ducroux, M. A. Ocampo, J. Kanitakis, E. Morelon, D. Jullien et al., Hidradenitis suppurativa after renal transplantation: Complete remission after switching from oral cyclosporine to oral tacrolimus, Journal of the American Academy of Dermatology, vol.71, issue.5, pp.210-211, 2014.

M. Arnadottir, E. Jonsson, and J. Jonsson, Inactivity of Hidradenitis Suppurativa After Renal Transplantation, Transplantation. sept, vol.82, issue.6, p.849, 2006.

G. Jemec, Methotrexate is of limited value in the treatment of hidradenitis suppurativa, Clin Exp Dermatol. sept, vol.27, issue.6, pp.528-537, 2002.

J. W. Frew, The contradictory inefficacy of methotrexate in hidradenitis suppurativa: a need to revise pathogenesis or acknowledge disease heterogeneity?, J Dermatolog Treat

K. F. Baker and J. D. Isaacs, Novel therapies for immune-mediated inflammatory diseases: What can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn's disease and ulcerative colitis?, Ann Rheum Dis, vol.77, issue.2, pp.175-87, 2018.

M. Arenbergerova, S. Gkalpakiotis, and P. Arenberger, Effective long-term control of refractory hidradenitis suppurativa with adalimumab after failure of conventional therapy, Int J Dermatol. déc, vol.49, issue.12, pp.1445-1454, 2010.

C. Bahillo-monné, H. Guerra, S. , S. Ortega, C. et al., Management of hidradenitis suppurativa with biological therapy: report of four cases and review of the literature, Dermatology (Basel), vol.229, issue.4, pp.279-87, 2014.

R. Blanco, V. M. Martínez-taboada, I. Villa, M. C. González-vela, H. Fernández-llaca et al., Long-term successful adalimumab therapy in severe hidradenitis suppurativa, Arch Dermatol. mai, vol.145, issue.5, pp.580-584, 2009.

D. Bosni?, B. ?arkovi?, M. Bare?i?, M. Zarkovic, and B. Ani?, Improvement of overlapping hidradenitis suppurativa and ankylosing spondylitis after the introduction of adalimumab, Reumatologia, vol.54, issue.6, pp.321-326, 2016.

D. Diamantova, I. Lomickova, and P. Cetkovska, Adalimumab treatment for hidradenitis suppurativa associated with Crohn's disease, Acta Dermatovenerol Croat, vol.22, issue.4, pp.291-294, 2014.

I. Gorovoy, A. Berghoff, and L. Ferris, Successful Treatment of Recalcitrant Hidradenitis Suppurativa with Adalimumab. Case Rep Dermatol, vol.1, pp.71-78, 2009.

V. Harde and U. Mrowietz, Treatment of severe recalcitrant hidradenitis suppurativa with adalimumab, J Dtsch Dermatol Ges. févr, vol.7, issue.2, pp.139-180, 2009.

S. Koilakou, D. Karapiperis, and C. Tzathas, A case of hidradenitis suppurativa refractory to anti-TNFalpha therapy in a patient with Crohn's disease, Am J Gastroenterol. janv, vol.105, issue.1, pp.231-233, 2010.

D. K. Moul and N. J. Korman, The cutting edge. Severe hidradenitis suppurativa treated with adalimumab, Arch Dermatol. sept, vol.142, issue.9, pp.1110-1112, 2006.

B. Murphy, G. Morrison, and P. Podmore, Successful use of adalimumab to treat pyoderma gangrenosum, acne and suppurative hidradenitis (PASH syndrome) following colectomy in ulcerative colitis, Int J Colorectal Dis. août, vol.30, issue.8, pp.1139-1179, 2015.

C. L. Reddick, M. N. Singh, and R. Chalmers, Successful treatment of superficial pyoderma gangrenosum associated with hidradenitis suppurativa with adalimumab, Dermatol Online J. 15 août, vol.16, issue.8, p.15, 2010.

R. Saraceno, G. Babino, A. Chiricozzi, A. Zangrilli, and S. Chimenti, PsAPASH: a new syndrome associated with hidradenitis suppurativa with response to tumor necrosis factor inhibition, J Am Acad Dermatol. janv, vol.72, issue.1, pp.42-44, 2015.

N. Scheinfeld, Treatment of coincident seronegative arthritis and hidradentis supprativa with adalimumab, J Am Acad Dermatol. juill, vol.55, issue.1, pp.163-167, 2006.

E. Sotiriou, C. Goussi, A. Lallas, E. Chovarda, Z. Apalla et al., A prospective open-label clinical trial of efficacy of the every week administration of adalimumab in the treatment of hidradenitis suppurativa, J Drugs Dermatol. mai, vol.11, issue.5, pp.15-20, 2012.

D. C. Van-rappard, M. Leenarts, L. Meijerink-van-'t-oost, and J. R. Mekkes, Comparing treatment outcome of infliximab and adalimumab in patients with severe hidradenitis suppurativa, J Dermatolog Treat. août, vol.23, issue.4, pp.284-293, 2012.

P. S. Yamauchi and N. Mau, Hidradenitis suppurativa managed with adalimumab, J Drugs Dermatol. févr, vol.8, issue.2, pp.181-184, 2009.

I. Miller, C. D. Lynggaard, S. Lophaven, C. Zachariae, D. N. Dufour et al., A double-blind placebo-controlled randomized trial of adalimumab in the treatment of hidradenitis suppurativa, Br J Dermatol. août, vol.165, issue.2, pp.391-399, 2011.

A. B. Kimball, M. M. Okun, D. A. Williams, A. B. Gottlieb, K. A. Papp et al., Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa, N Engl J Med. 4 août, vol.375, issue.5, pp.422-456, 2016.

S. Paradela, R. Rodríguez-lojo, R. Fernández-torres, P. Arévalo, and E. Fonseca, Long-term efficacy of infliximab in hidradenitis suppurativa, J Dermatolog Treat. août, vol.23, issue.4, pp.278-83, 2012.

B. Moriarty, Z. Jiyad, and D. Creamer, Four-weekly infliximab in the treatment of severe hidradenitis suppurativa, Br J Dermatol. avr, vol.170, issue.4, pp.986-993, 2014.

D. R. Adams, J. A. Yankura, A. C. Fogelberg, and A. Be, Treatment of hidradenitis suppurativa with etanercept injection, Arch Dermatol. mai, vol.146, issue.5, pp.501-505, 2010.

E. J. Giamarellos-bourboulis, E. Pelekanou, A. Antonopoulou, H. Petropoulou, F. Baziaka et al., An openlabel phase II study of the safety and efficacy of etanercept for the therapy of hidradenitis suppurativa, Br J Dermatol. mars, vol.158, issue.3, pp.567-72, 2008.

A. Pelekanou, T. Kanni, A. Savva, M. Mouktaroudi, M. Raftogiannis et al., Long-term efficacy of etanercept in hidradenitis suppurativa: results from an open-label phase II prospective trial, Exp Dermatol. juin, vol.19, issue.6, pp.538-578, 2010.

R. A. Lee, E. Dommasch, J. Treat, J. Sciacca-kirby, S. Chachkin et al., A prospective clinical trial of open-label etanercept for the treatment of hidradenitis suppurativa, J Am Acad Dermatol. avr, vol.60, issue.4, pp.565-73, 2009.

A. Tursi, Concomitant hidradenitis suppurativa and pyostomatitis vegetans in silent ulcerative colitis successfully treated with golimumab, Dig Liver Dis. déc, vol.48, issue.12, pp.1511-1513, 2016.

K. S. Leslie, S. V. Tripathi, T. V. Nguyen, M. Pauli, and M. D. Rosenblum, An open-label study of anakinra for the treatment of moderate to severe hidradenitis suppurativa, J Am Acad Dermatol. févr, vol.70, issue.2, pp.243-51, 2014.

V. Tzanetakou, T. Kanni, S. Giatrakou, A. Katoulis, E. Papadavid et al., Safety and Efficacy of Anakinra in Severe Hidradenitis Suppurativa: A Randomized Clinical Trial, JAMA Dermatol. janv, vol.152, issue.1, pp.52-61, 2016.

H. H. Van-der-zee and E. P. Prens, Failure of anti-interleukin-1 therapy in severe hidradenitis suppurativa: a case report, Dermatology (Basel), vol.226, issue.2, pp.97-100, 2013.

K. Zarchi, D. N. Dufour, and G. Jemec, Successful treatment of severe hidradenitis suppurativa with anakinra, JAMA Dermatol. oct, vol.149, issue.10, pp.1192-1196, 2013.

D. Menis, L. Maroñas-jiménez, A. M. Delgado-marquez, C. Postigo-llorente, and F. Vanaclocha-sebastián, Two cases of severe hidradenitis suppurativa with failure of anakinra therapy, Br J Dermatol. mars, vol.172, issue.3, pp.810-811, 2015.

V. Russo and A. Alikhan, Failure of Anakinra in a Case of Severe Hidradenitis Suppurativa, J Drugs Dermatol. 1 juin, vol.15, issue.6, pp.772-776, 2016.

T. Kanni, M. Argyropoulou, T. Spyridopoulos, A. Pistiki, M. Stecher et al., MABp1 Targeting IL-1? for Moderate to Severe Hidradenitis Suppurativa Not Eligible for Adalimumab: A Randomized Study, Journal of Investigative Dermatology. avr, vol.138, issue.4, pp.795-801, 2018.

T. Jaeger, C. Andres, M. Grosber, M. Zirbs, R. Hein et al., Pyoderma gangrenosum and concomitant hidradenitis suppurativa--rapid response to canakinumab (anti-IL-1?), Eur J Dermatol. juin, vol.23, issue.3, pp.408-418, 2013.

C. Houriet, S. Jafari, S. M. Thomi, R. Schlapbach, C. Borradori et al., Canakinumab for Severe Hidradenitis Suppurativa: Preliminary Experience in 2 Cases, JAMA Dermatol, vol.01, issue.11, pp.1195-1202, 2017.

B. Tekin, A. Salman, and T. Ergun, Hidradenitis suppurativa unresponsive to canakinumab treatment: A case report, Indian J Dermatol Venereol Leprol, vol.83, issue.5, pp.615-622, 2017.

N. Z. Sun, T. Ro, P. Jolly, and C. J. Sayed, Non-response to Interleukin-1 Antagonist Canakinumab in Two Patients with Refractory Pyoderma Gangrenosum and Hidradenitis Suppurativa, J Clin Aesthet Dermatol. sept, vol.10, issue.9, pp.36-44, 2017.

W. P. Gulliver, G. Jemec, and K. A. Baker, Experience with ustekinumab for the treatment of moderate to severe hidradenitis suppurativa, J Eur Acad Dermatol Venereol. juill, vol.26, issue.7, pp.911-915, 2012.

V. R. Sharon, M. S. Garcia, S. Bagheri, H. Goodarzi, C. Yang et al., Management of recalcitrant hidradenitis suppurativa with ustekinumab, Acta Derm Venereol. mai, vol.92, issue.3, pp.320-321, 2012.

E. M. Baerveldt, J. H. Kappen, H. B. Thio, J. A. Van-laar, P. M. Van-hagen et al., Successful long-term triple disease control by ustekinumab in a patient with Behcet's disease, psoriasis and hidradenitis suppurativa, Ann Rheum Dis. avr, vol.72, issue.4, pp.626-633, 2013.

M. I. Santos-pérez, S. García-rodicio, D. Olmo-revuelto, M. A. Pozo-román, and T. , Ustekinumab for hidradenitis suppurativa: a case report, Actas Dermosifiliogr. sept, vol.105, issue.7, pp.720-722, 2014.

J. L. Blok, K. Li, C. Brodmerkel, P. Horvátovich, M. F. Jonkman et al., Ustekinumab in hidradenitis suppurativa: clinical results and a search for potential biomarkers in serum, Br J Dermatol. avr, vol.174, issue.4, pp.839-885, 2016.

R. G. Casseres, J. S. Kahn, M. J. Her, and D. Rosmarin, Guselkumab in the treatment of hidradenitis suppurativa: A retrospective chart review, J Am Acad Dermatol. 15 déc, 2018.

L. Thorlacius, T. Riis, P. Jemec, and G. , Severe hidradenitis suppurativa responding to treatment with secukinumab: a case report, Br J Dermatol. juill, vol.179, issue.1, pp.182-187, 2018.

A. Schuch, T. Fischer, A. Boehner, T. Biedermann, and T. Volz, Successful Treatment of Severe Recalcitrant Hidradenitis Suppurativa with the Interleukin-17A Antibody Secukinumab, Acta Derm Venereol, vol.12, issue.1, pp.151-153, 2018.

A. Jørgensen, Y. Yao, and S. F. Thomsen, Therapeutic Response to Secukinumab in a 36-Year-Old Woman with Hidradenitis Suppurativa, Case Rep Dermatol Med, p.8685136, 2018.

P. Giuseppe, P. Nicola, C. Valentina, C. Elena, C. Salvatrice et al., A Case of Moderate Hidradenitis Suppurativa and Psoriasis Treated with Secukinumab, Ann Dermatol. août, vol.30, issue.4, pp.462-466, 2018.

L. Prussick, B. Rothstein, D. Joshipura, A. Saraiya, Y. Turkowski et al., Open-label, Investigator-Initiated, Single Site Exploratory Trial Evaluating Secukinumab, an anti IL17A monoclonal antibody, for Patients with Moderate-toSevere Hidradenitis Suppurativa, Br J Dermatol. 22 févr, 2019.

T. Kanni, O. Zenker, M. Habel, N. Riedemann, and E. J. Giamarellos-bourboulis, Complement activation in hidradenitis suppurativa: a new pathway of pathogenesis?, British Journal of Dermatology, vol.10, issue.2018

D. Sur,

P. Weber, S. Jafari, S. M. Yawalkar, N. Hunger, and R. E. , Apremilast in the treatment of moderate to severe hidradenitis suppurativa: A case series of 9 patients, Journal of the American Academy of Dermatology. juin, vol.76, issue.6, pp.1189-91, 2017.

A. Vossen, M. Van-doorn, H. H. Van-der-zee, and E. P. Prens, Apremilast for moderate hidradenitis suppurativa: Results of a randomized controlled trial, J Am Acad Dermatol. janv, vol.80, issue.1, pp.80-88, 2019.

F. R. Kerdel, F. A. Azevedo, K. Don, C. Don, F. A. Fabbrocini et al., Apremilast for the Treatment of Mild-toModerate Hidradenitis Suppurativa in a Prospective, Open-Label, Phase 2 Study, J Drugs Dermatol. 1 févr, vol.18, issue.2, pp.170-176, 2019.

M. Laroche, M. Teste, J. Vanoost, and H. Geniaux, Successful control of hidradenitis suppurativa with verapamil: a case report, Fundamental & Clinical Pharmacology. févr, vol.33, issue.1, pp.122-126, 2019.

A. Matsumori, R. Nishio, and Y. Nose, Calcium channel blockers differentially modulate cytokine production by peripheral blood mononuclear cells, Circ J. mars, vol.74, issue.3, pp.567-71, 2010.

W. Wang, Z. Li, Q. Meng, P. Zhang, P. Yan et al., Chronic Calcium Channel Inhibitor Verapamil Antagonizes TNF-?-Mediated Inflammatory Reaction and Protects Against Inflammatory Arthritis in Mice, Inflammation. oct, vol.39, issue.5, pp.1624-1658, 2016.

F. W. Danby, P. G. Hazen, and J. Boer, New and traditional surgical approaches to hidradenitis suppurativa, Journal of the American Academy of Dermatology, vol.73, issue.5, pp.62-67, 2015.

J. P. Ritz, N. Runkel, J. Haier, and H. J. Buhr, Extent of surgery and recurrence rate of hidradenitis suppurativa, Int J Colorectal Dis, vol.13, issue.4, pp.164-172, 1998.

S. Van-hattem, J. R. Spoo, B. Horváth, M. F. Jonkman, and F. Leeman, Surgical Treatment of Sinuses by Deroofing in Hidradenitis Suppurativa: Dermatologic Surgery, mars, vol.38, issue.3, pp.494-501, 2012.

S. C. Brown, N. Kazzazi, and P. H. Lord, Surgical treatment of perineal hidradenitis suppurativa with special reference to recognition of the perianal form, Br J Surg. déc, vol.73, issue.12, pp.978-80, 1986.

V. B. Van-der-wal and W. H. Bos, Chirurgisch behandeling van acne ectopica met "deroofing, Ned Tijdschr Dermatol Venereol, vol.10, pp.22-25, 2000.

D. C. Van-rappard, J. E. Mooij, and J. R. Mekkes, Mild to moderate hidradenitis suppurativa treated with local excision and primary closure: HS treated with local excision and primary closure, Journal of the European Academy of Dermatology and Venereology. juill, vol.26, issue.7, pp.898-902, 2012.

J. L. Blok, J. R. Spoo, F. Leeman, M. F. Jonkman, and B. Horváth, Skin-Tissue-sparing Excision with Electrosurgical Peeling (STEEP): a surgical treatment option for severe hidradenitis suppurativa Hurley stage II/III, Journal of the European Academy of Dermatology and Venereology. févr, vol.29, issue.2, pp.379-82, 2015.

I. Janse, A. Bieniek, B. Horváth, and ?. Matusiak, Surgical Procedures in Hidradenitis Suppurativa, Dermatologic Clinics. janv, vol.34, issue.1, pp.97-109, 2016.

A. Bieniek, ?. Matusiak, I. Chlebicka, and J. C. Szepietowski, Secondary intention healing in skin surgery: our own experience and expanded indications in hidradenitis suppurativa, rhinophyma and non-melanoma skin cancers: Secondary intention healing in skin surgery, Journal of the European Academy of Dermatology and Venereology. août, vol.27, issue.8, p.452, 1985.

I. E. Deckers, Y. Dahi, H. H. Van-der-zee, and E. P. Prens, Hidradenitis suppurativa treated with wide excision and second intention healing: a meaningful local cure rate after 253 procedures, Journal of the European Academy of Dermatology and Venereology. mars, vol.32, issue.3, pp.459-62, 2018.

Y. E. Chen, T. Gerstle, K. Verma, M. D. Treiser, A. B. Kimball et al., Management of Hidradenitis Suppurativa Wounds with an Internal Vacuum-Assisted Closure Device: Plastic and Reconstructive Surgery, mars, vol.133, issue.3, pp.370-377, 2014.

R. Parrado, M. Cadena, A. Vergara, D. Cadena, and J. G. Chalela, The role of negative pressure wound therapy in the management of hidradenitis suppurativa: a case report and literature review: The role of negative pressure wound therapy in the management of hidradenitis suppurativa, International Wound Journal. févr, vol.14, issue.1, pp.35-44, 2017.

S. Ge, H. Orbay, R. P. Silverman, and Y. M. Rasko, Negative Pressure Wound Therapy with Instillation and Dwell Time in the Surgical Management of Severe Hidradenitis Suppurativa. Cureus, vol.17

D. Sur,

A. Mehdizadeh, P. G. Hazen, F. G. Bechara, N. Zwingerman, M. Moazenzadeh et al., Recurrence of hidradenitis suppurativa after surgical management: A systematic review and meta-analysis, Journal of the American Academy of Dermatology, vol.73, issue.5, pp.70-77, 2015.

E. Chen and H. I. Friedman, Management of Regional Hidradenitis Suppurativa With Vacuum-Assisted Closure and Split Thickness Skin Grafts: Annals of Plastic Surgery, vol.67, pp.397-401, 2011.

T. Jianbing, C. Biao, L. Qin, and W. Yanhong, Topical negative pressure coupled with split-thickness skin grafting for the treatment of hidradenitis suppurativa: a case report: Case report of buttocks hidradenitis suppurativa, International Wound Journal. juin, vol.12, issue.3, pp.334-341, 2015.

F. B. Pearce and K. A. Richardson, Negative pressure wound therapy, staged excision and definitive closure with splitthickness skin graft for axillary hidradenitis suppurativa: a retrospective study, Journal of Wound Care. janv, vol.26, issue.Sup1, pp.36-42, 2017.

D. M. Saunte and J. Lapins, Lasers and Intense Pulsed Light Hidradenitis Suppurativa, Dermatologic Clinics. janv, vol.34, issue.1, pp.111-120, 2016.

E. M. Finley and J. L. Ratz, Treatment of hidradenitis suppurativa with carbon dioxide laser excision and second-intention healing, Journal of the American Academy of Dermatology. mars, vol.34, issue.3, pp.465-474, 1996.

V. Madan, E. Hindle, W. Hussain, and P. J. August, Outcomes of treatment of nine cases of recalcitrant severe hidradenitis suppurativa with carbon dioxide laser, British Journal of Dermatology. déc, vol.159, issue.6, pp.1309-1323, 2008.

P. G. Hazen and B. P. Hazen, Hidradenitis Suppurativa: Successful Treatment Using Carbon Dioxide Laser Excision and Marsupialization, Dermatologic Surgery. févr, vol.36, issue.2, pp.208-221, 2010.

A. C. Krakowski, S. Admani, N. S. Uebelhoer, L. F. Eichenfield, and P. R. Shumaker, Residual Scarring From Hidradenitis Suppurativa: Fractionated CO 2 Laser as a Novel and Noninvasive Approach, Pediatrics. janv, vol.133, issue.1, pp.248-51, 2014.

E. Tierney, B. H. Mahmoud, C. Hexsel, D. Ozog, and I. Hamzavi, Randomized Control Trial for the Treatment of Hidradenitis Suppurativa with a Neodymium-Doped Yttrium Aluminium Garnet Laser: Dermatologic Surgery, août, vol.35, issue.8, pp.1188-98, 2009.

B. H. Mahmoud, E. Tierney, C. L. Hexsel, J. Pui, D. M. Ozog et al., Prospective controlled clinical and histopathologic study of hidradenitis suppurativa treated with the long-pulsed neodymium:yttrium-aluminium-garnet laser, Journal of the American Academy of Dermatology. avr, vol.62, issue.4, pp.637-682, 2010.

L. Y. Xu, D. R. Wright, B. H. Mahmoud, D. M. Ozog, D. A. Mehregan et al., Histopathologic Study of Hidradenitis Suppurativa Following Long-Pulsed 1064-nm Nd:YAG Laser Treatment, Archives of Dermatology. 20 sept, vol.147, issue.1, p.21, 2010.

D. Koch, P. Pratsou, W. Szczecinska, S. Lanigan, and A. Abdullah, The diverse application of laser hair removal therapy: a tertiary laser unit's experience with less common indications and a literature overview, Lasers in Medical Science. janv, vol.30, issue.1, pp.453-67, 2015.

A. Downs, Smoothbeam TM laser treatment may help improve hidradenitis suppurativa but not Hailey-Hailey disease, Journal of Cosmetic and Laser Therapy. janv, vol.6, issue.3, pp.163-167, 2004.

D. Piccolo, D. Marcantonio, D. Crisman, G. Cannarozzo, G. Sannino et al., Unconventional Use of Intense Pulsed Light, BioMed Research International, vol.2014, pp.1-10, 2014.

L. Highton, W. Chan, N. Khwaja, and J. Laitung, Treatment of Hidradenitis Suppurativa with Intense Pulsed Light: A Prospective Study: Plastic and Reconstructive Surgery, août, vol.128, issue.2, pp.459-66, 2011.

P. Theut-riis, D. M. Saunte, V. Sigsgaard, C. Wilken, and G. Jemec, Intense pulsed light treatment for patients with hidradenitis suppurativa: beware treatment with resorcinol, Journal of Dermatological Treatment. 19 mai, vol.29, issue.4, pp.385-392, 2018.

S. Mordon, Treating hidradenitis suppurativa with photodynamic therapy, Journal of Cosmetic and Laser Therapy. 19 mai, vol.20, issue.4, pp.223-231, 2018.

N. Scheinfeld, NYC NY 10019 Scheinfeld@earthlink.net, p.8

E. Agut-busquet, J. Romaní, Y. Gilaberte, A. García-malinis, M. Ribera-pibernat et al., Photodynamic therapy with intralesional methylene blue and a 635 nm light-emitting diode lamp in hidradenitis suppurativa: a retrospective follow-up study in 7 patients and a review of the literature, Photochemical & Photobiological Sciences, vol.15, issue.8, pp.1020-1028, 2016.

L. M. Valladares-narganes, M. A. Rodríguez-prieto, M. D. Blanco-suárez, C. Rodriguez-lage, and I. García-doval, Treatment of hidradenitis suppurativa with intralesional photodynamic therapy using a laser diode attached to an optical cable: a promising new approach, British Journal of Dermatology. avr, vol.172, issue.4, pp.1136-1145, 2015.

S. Valladares, M. J. , E. Salvado, N. , R. Prieto et al., Treatment of hidradenitis suppurativa with intralesional photodynamic therapy with 5-aminolevulinic acid and 630nm laser beam, Journal of Dermatological Science. mars, vol.85, issue.3, pp.241-247, 2017.

M. A. Fadel and A. A. Tawfik, New topical photodynamic therapy for treatment of hidradenitis suppurativa using methylene blue niosomal gel: a single-blind, randomized, comparative study, Clinical and Experimental Dermatology. mars, vol.40, issue.2, pp.116-138, 2015.

P. M. Tricarico, L. Zupin, G. Ottaviani, K. Rupel, F. Celsi et al., Photobiomodulation as potential novel third line tool for non-invasive treatment of Hidradenitis Suppurativa, G Ital Dermatol Venereol. 23 avr, 2019.

P. M. Tricarico, L. Zupin, G. Ottaviani, S. Pacor, F. Jean-louis et al., Photobiomodulation therapy promotes in vitro wound healing in nicastrin KO HaCaT cells, Journal of Biophotonics. déc, vol.11, issue.12, p.201800174, 2018.

A. Molina-leyva, L. Salvador-rodriguez, A. Martinez-lopez, and C. Cuenca-barrales, Effectiveness, safety and tolerability of drainage and punch-trocar-assisted cryoinsufflation (cryopunch) in the treatment of inflammatory acute fluid collections in hidradenitis suppurativa patients, Journal of the European Academy of Dermatology and Venereology. mai, vol.33, issue.5, pp.221-224, 2019.

J. Gandhi, O. Seyam, N. Smith, G. Joshi, S. Vatsia et al., Clinical utility of hyperbaric oxygen therapy in genitourinary medicine, Medical Gas Research, vol.8, issue.1, p.29, 2018.

C. Marasca, M. C. Annunziata, M. Napolitano, and G. Fabbrocini, Unconventional therapies for hidradenitis suppurativa, Expert Review of Clinical Pharmacology. 2 sept, vol.11, issue.9, pp.879-87, 2018.

L. E. Provini, J. J. Stellar, M. N. Stetzer, P. D. Nguyen, and J. M. , Combination hyperbaric oxygen therapy and ustekinumab for severe hidradenitis suppurativa. Pediatric Dermatology, vol.25

D. Sur,

G. Uzun, Y. Özdemir, M. Mutluo?lu, and B. Güleç, Hyperbaric Oxygen Therapy as an Adjunct to Surgical Treatment of Extensive Hidradenitis Suppurativa, World Journal of Surgery. avr, vol.34, issue.4, pp.861-863, 2010.

M. Trombetta, E. D. Werts, and D. Parda, The role of radiotherapy in the treatment of hidradenitis suppurativa: case report and review of the literature, Dermatol Online J. 15 févr, vol.16, issue.2, p.16, 2010.

M. Maher and L. Larsen, A case of radiation-induced localized exacerbation of hidradenitis suppurativa, JAAD Case Reports. janv, vol.2, issue.1, pp.44-50, 2016.

R. Haber, J. Gottlieb, A. Zagdanski, M. Battistella, and H. Bachelez, Radiation-induced hidradenitis suppurativa: A case report, JAAD Case Reports. mai, vol.3, issue.3, pp.182-186, 2017.

P. Perng, J. G. Zampella, and G. A. Okoye, Management of hidradenitis suppurativa in pregnancy, Journal of the American Academy of Dermatology. mai, vol.76, issue.5, pp.979-89, 2017.

, En présence des Maîtres de cette FACULTE et de mes chers CONDISCIPLES, je promets et je jure d'être fidèle aux lois de l'Honneur et de la Probité dans l

, Admise dans l'intérieur des maisons, mes yeux ne verront pas ce qui s'y passe, ma langue taira les secrets qui me seront confiés et mon état ne servira pas à corrompre les moeurs ni à favoriser le crime

, Respectueuse et reconnaissante envers mes MAÎTRES, je rendrai à leurs enfants l'instruction que j'ai reçue de leurs pères

, Que les HOMMES m'accordent leur estime si je suis fidèle à mes promesses. Que je sois couverte d'OPPROBRE et méprisée de mes confrères si j'y manque

, ? Hidrosadénite suppurée ? Maladie de Verneuil ? Acne inversa ? Occlusion folliculaire ? Dysbiose ? Biofilms ? Immunité innée ? Susceptibilité génétique ? Tabagisme ? Obésité ? Qualité de vie ? Dépression ? Douleur ? Syndromes auto-inflammatoires ? Syndrome métabolique ? Maladie de Crohn ? Spondylarthropathies ? Soutien psychologique ? Règles hygiéno-diététiques ? Antibiothérapie ? Biothérapies ? Anti-TNF ? Chirurgie ? Deroofing ? Laser CO2 ? Laser épilatoire